Diabetes Care·11 AugsuPAR Identifies Treatment-Resistant Inflammatory Risk Beyond hs-CRP in Type 2 Diabetes With Coronary Artery Disease: An Ancillary Analysis of BARI 2DTrial in peopleBiomarkersPaper